Bioactive Phytol from Thymus vulgaris, a promising source of alternative medicine to combat blaKPC and blaOXA-48 genotypes of Klebsiella pneumoniae: A retrospective in vitro and in silico approach
- PMID: 40553922
- DOI: 10.1016/j.micpath.2025.107813
Bioactive Phytol from Thymus vulgaris, a promising source of alternative medicine to combat blaKPC and blaOXA-48 genotypes of Klebsiella pneumoniae: A retrospective in vitro and in silico approach
Abstract
Carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a significant public health challenge due to its multidrug resistance and limited treatment options. This study investigates the antibacterial potential of Thymus vulgaris ethanolic extract and its bioactive compounds against multidrug-resistant K. pneumoniae strains harboring blaKPC and blaOXA-48 carbapenemase genes. The presence of these resistance genes was confirmed by multiplex PCR. The extract exhibited a dose-dependent inhibitory effect, with a maximum inhibition zone of 18 ± 1.5 mm at 100 μg. Chromatographic techniques, including thin-layer chromatography (TLC) and column chromatography, yielded six fractions, among which fraction F3 showed the strongest antibacterial activity. Gas chromatography-mass spectrometry (GC-MS) and ultra-performance liquid chromatography (UPLC) analyses identified phytol as the predominant bioactive constituent. Further evaluation of phytol revealed a minimum inhibitory concentration (MIC) of 125 μg/mL and a minimum bactericidal concentration (MBC) of 250 μg/mL against CRKP. Alamar Blue viability assays and bacterial culture confirmed phytol's bacteriostatic and bactericidal effects, independent of the ethanol solvent. These findings suggest that phytol inhibits bacterial growth, possibly through membrane-targeting mechanisms. Notably, this study is among the first to comprehensively assess phytol's efficacy against carbapenem-resistant K. pneumoniae strains carrying blaKPC and blaOXA-48 genes, integrating molecular characterization, chromatographic purification and antimicrobial activity. Overall, the results highlight phytol as a promising natural agent to combat multidrug-resistant bacterial infections and address the urgent global threat of antibiotic resistance.
Keywords: Antibacterials; Carbapenem-resistant enterobacteriacae; Klebsiella pneumoniae; Molecular docking; Phytol; Thymus vulgaris.
Copyright © 2025 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Antibacterial efficacy of cefoperazone/sulbactam in combination with various antimicrobials against carbapenem-resistant Klebsiella pneumoniae.Acta Microbiol Immunol Hung. 2025 Apr 23;72(2):106-112. doi: 10.1556/030.2025.02577. Print 2025 Jun 20. Acta Microbiol Immunol Hung. 2025. PMID: 40266683
-
Antimicrobial resistance and phylogenetic lineages of KPC-2-producing blood-borne Klebsiella pneumoniae subsp. pneumoniae from Kolkata, India during 2015-2024: Emergence of Klebsiella pneumoniae subsp. pneumoniae with blaKPC-2, blaNDM, and blaOXA-48-like triple carbapenemases.Microbiol Spectr. 2025 Aug 5;13(8):e0012625. doi: 10.1128/spectrum.00126-25. Epub 2025 Jun 12. Microbiol Spectr. 2025. PMID: 40503825 Free PMC article.
-
Exploring the bioactive compounds of Carica papaya leaves: phytol's role in combatting antibiotic-resistant bacteria.Front Cell Infect Microbiol. 2025 Jul 7;15:1564787. doi: 10.3389/fcimb.2025.1564787. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40692687 Free PMC article.
-
The mechanisms of resistance, epidemiological characteristics, and molecular evolution of carbapenem-resistant hypervirulent Klebsiella pneumoniae.Lab Med. 2025 Jul 11;56(4):323-335. doi: 10.1093/labmed/lmae110. Lab Med. 2025. PMID: 40072365 Review.
-
"Global divide in carbapenem resistance and hypervirulence of Klebsiella pneumonia: comparing trends in India and developed nations"- a comprehensive review.J Antibiot (Tokyo). 2025 Jul;78(8):457-471. doi: 10.1038/s41429-025-00833-8. Epub 2025 Jun 3. J Antibiot (Tokyo). 2025. PMID: 40461635 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous